John Monahan (scientist)
John Monahan (John James Monahan) is an Irish-born biochemist and CEO of biotechnology and gene therapy companies in the United States.
Education
[edit]Monahan is from County Kildare in Ireland and was educated at Newbridge College, where he was the inaugural winner of the BT Young Scientist & Technology Exhibition in 1965, his project was an explanation of the process of digestion in the human stomach.[1][2]
He holds a Bachelor of Science from University College Dublin and a PhD in Biochemistry from McMaster University in Ontario, Canada.[3]
Work and research
[edit]Monahan founded Avigen Inc in Alameda, California a company which became a leader in its sector for the development of pharmaceutical products for the treatment of serious human disease, and raised over $235 million USD through its initial public offering on the NASDAQ stock exchange.[4]
He has directed a number of preclinical and clinical trials and led biotech and pharmaceutical research programmes.[3]
He is current executive vice president research & development for Synthetic Biologics and sits on the scientific advisory board of Agilis Biotherapeutics, LLC.[5]
Monahan also sits on the board of directors at IdentiGEN, the Irish-based DNA analysis company.[4]
References
[edit]- ^ "Key facts". BT Young Scientist & Technology Exhibition. Retrieved 12 June 2016.
- ^ Kennedy, John (10 January 2014). "Interview with the first-ever young scientist exhibition winner (video)". Silicon Republic. Retrieved 12 June 2016.
- ^ a b "John Monahan Ph.D." Bloomberg. Retrieved 12 June 2016.
- ^ a b "IdentiGEN Appoints Biotech Entrepreneur Dr. John Monahan to Board of Directors". IdentiGEN Ltd. Retrieved 12 June 2016.
- ^ "Dr. John Monahan, a Veteran in Biotechnology and Gene Therapy Companies, Joins the lllScientific lllAdvisory llllBoard of Agilis Biotherapeutics". Business Wire. 3 June 2014. Retrieved 19 December 2021 – via BusinessWire.